- Home
- CRDF vs REKR Comparison
CRDF vs REKR Comparison
Compare CRDF & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDF | REKR |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.1M | 151.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDF | REKR |
|---|---|---|
| Price | $2.93 | $1.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.63 | N/A |
| AVG Volume (30 Days) | 914.5K | ★ 2.8M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $501,000.00 | ★ $49,028,000.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | N/A | $22.78 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $1.90 | $0.62 |
| 52 Week High | $5.00 | $3.42 |
Technical Indicators
Market Signals| Indicator | CRDF | REKR |
|---|---|---|
| Relative Strength Index (RSI) | 76.82 | 35.18 |
| Support Level | $2.32 | $1.54 |
| Resistance Level | $2.59 | $1.71 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 99.34 | 8.29 |
Price Performance
Historical ComparisonAbout CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.